Core Insights - RetinalGenix Technologies Inc. has made significant advancements in its patent portfolio, positioning itself at the forefront of home and remote health monitoring for ocular and systemic diseases [1][5] Patent Developments - Recently granted patents, including U.S. Patent Application No. 2024/0099581 Al, cover key aspects of real-time home and remote ocular monitoring and scalable physician alert systems [2] - The current patent focuses on expanding the mapping of the peripheral retina, which is crucial for identifying diseases such as early retinal changes associated with diabetes and biomarkers linked to Alzheimer's disease [3] Technology Integration - RetinalGenix's proprietary DNA/RNA/GPS Pharmaco-Genetic Mapping™ platform is planned to integrate with the high-resolution retinal imaging system, empowering patients and clinicians with actionable biomarker information [4] - The combination of these technologies aims to reduce the frequency of office visits and streamline critical care workflows across various settings, including homes and clinics [4] Market Positioning - The company's patents provide strong protection for device, system, and digital workflow innovations, setting it apart in the industry and positioning it for new partnerships and licensing opportunities [5][6] - The advancements are expected to enhance strategic competitive advantage and expand revenue generation opportunities in the telemedicine, ophthalmology, and healthcare technology sectors [6]